| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
1,24,25-trihydroxyvitamin D3
3
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: RN given refers to (3beta,5Z,7E)-isomer
Also Known As:1,24,25-trihydroxycholecalciferol; 1,24,25-trihydroxyvitamin D3, (1alpha,3beta,5Z,7E)-isomer; 1,24,25-trihydroxyvitamin D3, (1alpha,3beta,5Z,7E,24R)-isomer; 1,24,25-trihydroxyvitamin D3, (1alpha,3beta,5Z,7E,24S)-isomer; 1,24,25-trihydroxyvitamin D3, (3beta,5Z,7E,24R)-isomer; (3 beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,24,25- tetrol
Bio-Agent Context: Research Results
Related Diseases
| 1. | Osteosarcoma (Osteogenic Sarcoma)
06/01/1990
- "The identified metabolites produced from 1,25-(OH)2D3 by the human osteosarcoma cells include 1,24,25-trihydroxyvitamin D3; 24-oxo-1,25-dihydroxyvitamin D3; 24-oxo-1,23,25-trihydroxyvitamin D3; and 24,25,26,27-tetranor-1,23-dihydroxyvitamin D3"
Order ALL the reference details at left... |
| 2. | Neoplasms (Cancer)
05/01/2005
- "However, production of inactive 1,24,25-trihydroxyvitamin D3 was also significantly higher in tumors (84.8 +/- 11.7 versus 33.6 +/- 8.5 fmol/h/mg protein; P < 0.01)"
Order ALL the reference details at left... |
| 3. | Bone Resorption
03/01/1980
- "Administration of 1,25-dihydroxycholecalciferol or 1,24,25-trihydroxycholecalciferol to TPTX female rats normalized the basal bone resorption of the fetus whereas injection of 24,25-dihydroxycholecalciferol was without effect"
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | 24,25-Dihydroxyvitamin D 3 (24,25 Dihydroxyvitamin D 3)
|
| 2. | Calcitriol (Calcijex)
|
Best Treatments:
Research Summary Report
on Osteosarcoma
Research Summary Report
on Osteosarcoma
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 273 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |